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PhosphorylationHuman papillomavirus type 16 (HPV16) is the major causative agent of cervical cancer. Studies regarding the
early binding and signaling molecules that play a signiﬁcant role in infection are still lacking. The current
study analyzes the role of heparan sulfate, integrins, and the signaling molecule FAK in HPV16 infection of
human adult keratinocytes cell line (HaCaTs). Our data demonstrate that infection requires the binding of
viral particles to heparan sulfate followed by activation of focal adhesion kinase through an integrin.
Infections were reduced in the presence of the FAK inhibitor, TAE226. TAE226 was observed to inhibit viral
entry to the early endosome a known infectious route. These ﬁndings suggest that FAK can serve as a novel
target for antiviral therapy.. Department of Microbiology
ne and Science, North Chicago,
du (P.I. Meneses).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Human papillomavirus type 16 (HPV16) is a nonenveloped virus of
the Papillomaviridae family. This family of double-stranded DNA viruses
have high tropism for squamous epithelial tissue and have been
recognized as the etiologic agent for human cancers (Bosch et al., 2002,
1995; Zur Hausen, 1991). HPV16 is the genotype most often associated
with cases of invasive cervical carcinoma (Bosch et al., 2002).
HPV16 infection begins with the attachment of the viral particle
(virion) to the target cells. This attachment stephas been suggested to be
mediated by heparan sulfate and to be followed by a secondary binding
event, putatively an integrin complex (Evander et al., 1997; Giroglou et
al., 2001; Joyce et al., 1999; McMillan et al., 1999; Shafti-Keramat and
Handisurya, 2003). Following attachment and binding to the putative
secondary receptor at the cell surface, HPVs have been shown to be
internalized via several pathways including clathrin-dependent,
caveolin-, or clathrin–caveolin-independent pathways (Bousarghin et
al., 2003; Day et al., 2003; Hindmarsh and Laimins, 2007; Laniosz et al.,
2009, 2008; Smith et al., 2007; Spoden et al., 2008). An explanation for
the various ﬁndingsmay be the cell type used and themethod of virions
production. Clathrin-mediated endocytosis pathway has been shownusing cell lines that include C-127 cells, COS-7 cells, and HaCaTs cells,
alongside a battery of compounds, dominant negatives, and genetic
approaches (Bousarghin et al., 2003; Day et al., 2003; Laniosz et al.,
2008). Our previous ﬁndings show that after clathrin-mediated
endocytosis, HPV16 viral particles trafﬁc to a caveolin-1-positive vesicle,
and particles can be found in the endoplasmic reticulum (Laniosz et al.,
2008). A role for dynamin in HPV16, and HPV31 infection, presumably
via pinching of vesicles from the plasmamembrane, has been described
(Abban et al., 2008; Smith et al., 2007). Recently, Spoden et al. (2008)
described the clathrin-, caveolin-, and dynamin-independent entry for
HPV16usingHeLa cells and293TT. In this study, the authors showed the
involvement of tetraspanin-enriched domains in HPV16 endocytosis.
Emerging data on the initial steps of viral infection have shown that
viruses that bind to heparan sulfate and integrin complexes at the cell
surface activate cellular signaling molecules including focal adhesion
kinase (FAK), PyK2, Src kinase, Rho and Rac1 GTPases, and phospha-
tidylinositol 3-kinase (PI3-K) (Fothergill and McMillan, 2006; Krishnan
et al., 2006; Marsh and Helenius, 2006; Sharma-Walia et al., 2004).
These viruses include human herpes virus 8 (HHV-8), HIV, and the JCV
virus. HHV-8 has been shown to induce both FAK phosphorylation and
PI3-K (Naranatt et al., 2003; Sharma-Walia et al., 2004). In 1997, Davis
et al. (1997) showed that the HIV virus induces PyK2 phosphorylation.
In addition, JCVandHHV-8viruses havebeen shown to activate the Ras/
MAP kinase pathway (Naranatt et al., 2003; Payne et al., 2001; Querbes
et al., 2004). Signaling studies in HPV have shown that HPV31 and
HPV16 binding and entry can result in the activation of a tyrosine kinase
Fig. 1. Heparan sulfate proteoglycans role in HPV16 binding and infection. (A) HaCaT cells were incubated for 2 hours only with puriﬁed 3[H] thymidine-labeled HPV16 reporter
virions or with labeled virions previously incubated with 50 μg/ml soluble heparin. Bound radioactivity was precipitated with TCA and counted by scintillation counter. First bar
shows background cellular cpm in the absence of virus, second bar represents virions cpm in the absence of soluble heparin, and third bar represents bound virions in the presence of
soluble heparin. (B) Binding of 3[H] thymidine-labeled HPV16 to HaCaT cells pretreated with heparinase I. Radioactivity was precipitated with TCA and counted on a scintillation
counter. Counts: Bar 1, buffer background; bar 2, control untreated HaCaTs; bar 3, total bound virions; bars 4–7, bound virions cpm in heparinase I-treated cells with 1 U, 2 U, 4 U, and
10 U, respectively. Each sample was plated with 1×105 cells. Experiments were done in triplicate, and error bars represent sample means±SD. Signiﬁcance level was set at *pb0.05.
(C) Cells were infected with nonradioactive HPV16 GFP reporter PsVs for 48 hours. Samples: Bar 1, uninfected HaCaTs; bar 2, virus infection; bar 3, HaCaT infected with HPV16 GFP
reporter PsVs preincubated with 50 μg/ml soluble heparin; bars 4–6, infection of HaCaT cells pretreated with increasing units of heparinase I before addition of HPV16 GFP reporter
PsVs; bar 7, soluble heparin-treated cells before addition of HPV16 GFP reporter PsVs. Each condition was performed in triplicate and error bars represent sample means±SD.
Signiﬁcance level was set at *pb0.05.
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Schelhaas et al., 2008; Smith et al., 2008). These signaling events may
help cytoskeletal rearrangement and ﬁlopodia formation to promote
HPV viral uptake from the extracellular matrix (ECM).
The goal of our study was to determine the attachment, secondary
binding, and early signaling molecules that may be required in the
infectious entry route of HPV16 in the human keratinocyte cell line,
HaCaTs, a nontumorigenic keratinocyte cell line derived from adult
skin that have a normal differentiation capacity (Boukamp et al., 1988,
1997; Breitkreutz et al., 1998). We have observed that HPV16
pseudovirions (HPV16 PsVs) are dependent on heparan sulfate for
initial attachment, preferentially infect cells in the presence of α6
integrin receptor, and induce the phosphorylation, and thus activation
of FAK. Our experiments showed that FAK phosphorylation is
necessary for virus entry to the early endosome. Using TAE226, a
small molecular bis-anilino pyrimidine compound that inhibits FAK
and PyK2 phosphorylation, we observed a signiﬁcant decrease in
HPV16 infection. In addition, infection analysis performed in FAK
knockout cells and matched controls substantiated the biologicalFig. 2. Integrin proﬁle of HaCaTs, KH-SV α6 +/+ and BOUA-SV α6 −/− cells. Integrin p
performed using the alpha/beta integrin-mediated cell adhesion array combo kit. Baseline c
ﬂuorescence units for each cell type. Flow cytometry analysis of α6 expression on HaCaTssigniﬁcance of FAK activity. Our data also showed that HPV16 binding
induces ﬁlopodia formation on cells, possibly enhancing virus entry as
previously reported for HPV31 (Smith et al., 2008).
Results
Initial binding steps of HPV16 PsVs on human keratinocyte immortalized
cell line HaCaT
Wewanted to determine if heparan sulfate at the cells surface was
mediating initial PsV attachment. Our data showed that the binding of
radioactive labeled HPV16 PsVs (i.e., DNA incorporating tritiated
thymidine, 3[H]-HPV16 PsV) to HaCaTs (Fig. 1A, middle lane) is
blocked in the presence of soluble heparin (Fig. 1A, last bar). Because
addition of soluble heparin to PsVs may result in the coating of the
PsVs which may prevent the binding of the virus to a non-heparan
sulfate molecule, we removed cell surface heparan sulfate molecules
using heparinase I (Fig. S1). Our data indicated that the enzymatic
removal of heparan sulfate decreased the level of binding by over 70%roﬁling of HaCaTs (A1), KH-SV α6 +/+ (B1), and BOUA-SV α6 −/− cells (C1) was
ontrols (cells alone) were used for standardizing and measuring the increase in relative
(A2), KH-SV α6 +/+ (B2), and BOUA-SV α6 −/− cells (C2).
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Fig. 3. HPV16 infection in human keratinocyte lines. HPV16 GFP reporter PsVs were
added to HaCaTs, KH-SV α6 +/+, and BOUA-SV α6 −/− cells. Percent infection was
determined via ﬂow cytometry analysis. Infection of HaCaT cells bar 1, KH-SV α6 +/+
cells bar 2, BOUA-SV α6 −/− cells bar 3. Error bars show the standard deviation of
three experiments in which 10,000 cells were analyzed for GFP expression to obtain the
percent of infected cells. Signiﬁcance level was set at *pb0.05.
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binding was not observed with increased heparinase I treatment,
suggesting either that heparinase I treatment is less than 100%
efﬁcient (supported by the FACS data shown in Fig. S1A) or that there
is heparan sulfate-independent binding of our radiolabeled PsVs to
the HaCaT cells. Next, we determined the level of infection using PsVs
previously incubated with soluble heparin and the infection level of
PsVs on heparinase I-treated cells (Fig. 1C). Data demonstrated that
preincubation of virions with soluble heparin blocked infection
(Fig. 1C, lane 3 as compared to uncoated PsV lane 2), while
preincubating the cells with soluble heparin before addition of PsV
(cells were washed before PsV addition) did not interfere with
infection (Fig. 1C, lane 7). These data suggested that soluble heparin
was coating or masking epitopes on the viral capsid needed for
binding. Infection was also reduced if cells were heparinase I-treated
before infection (Fig. 1C, lanes 4–6). As with the binding assay,
increasing the amount of heparinase I beyond 2 units did not decrease
infection further. This suggested that either heparinase I treatment
was less than 100% efﬁcient or that a non-heparan sulfate binding
event can lead to infection.
Integrin proﬁle of human keratinocytes
After the initial interaction of PsVs with heparan sulfate, it is
hypothesized that a conformational change occurs leading to a
secondary binding event (Selinka et al., 2003). This secondary binding
has been suggested to involve an integrin molecule, and a likely
candidate is the α6 integrin molecule (Evander et al., 1997; McMillan
et al., 1999). Thus, before addressing the role of integrins in virus
infection in HaCaT cells, KH-SV and BOUA-SV α6 integrin negative
cells, we determined the integrin proﬁle of these cells. We assayed for
existing integrins at the cell's surface using an integrin proﬁling kit (a
modiﬁed ELISA), and we used FACS analysis to determine the level of
α6 (α6 is not part of the proﬁle kit). Levels of integrins were
compared to background levels. We determined that HaCaT cells
contained β1, α2, β2, α3, β4, β6, and possibly αV (Fig. 2A1) and α6
(Fig. 2A2). KH-SV and BOUA-SV α6 integrin negative cell lines had
above background levels of β1, α2, β2, α3, α5, β6, and possibly αV
(Figs. 1B1 and C1). KH-SV cells also had above background levels ofα1
and β4. We conﬁrmed the presence and absence of α6 integrin in
these latter cell lines (Figs. 2B2 and C2, respectively).
Infection is lowest in α6 integrin null cells
We proceeded to compare the infection levels in the three human
keratinocyte cell lines using HPV16 PsVs (Fig. 3). Data showed
that infection was most efﬁcient in HaCaT cells (42%) as compared to
KH-SV α6 cells (18%) and BOUA-SV α6 negative cells (6%). The
correlation between α6 levels and infection suggested that α6 may
be important in infection. Also, the low level of infection observed in
α6-null cells suggested that infectionmay not be not 100% dependent
on α6 integrin.
HPV16 PsVs induce FAK phosphorylation upon binding to HaCaTs
We wanted to determine if a signal transduction event was
induced upon PsVs binding to target cells because of the proposed role
of signaling events in virus entry and infection (Fothergill and
McMillan, 2006; Krishnan et al., 2006; Sharma-Walia et al., 2004).
The primary activated molecule upon integrin binding has been
shown to be FAK; activated FAK can be differentiated from quiescent
FAK by means of phosphorylation at -Tyr397 (Sieg et al., 1999;
Krishnan et al., 2006). To determine if HPV16 induced FAK
phosphorylation, we analyzed the levels of phosphorylated FAK
(pFAK-Tyr397) after virus binding to serum starved HaCaT cells
(Fig. 4). Cells were serum starved to normalize the levels of pFAK-Tyr397. Although the protein levels of total FAK (tFAK) were
unchanged, FAK phosphorylation (i.e., pFAK-Tyr397) increased 3.3-
fold and 5.0-fold after 10 and 30 minutes respectively post PsV
binding as compared to control uninfected cells (Fig. 4A, lanes 2 and 3
as compared to lane 1). We detected increases in pFAK-Tyr397 level at
an MOI of 0.15 but did not observe an increase using an MOI of 0.015
(data not shown) or 0.0015 at 5–30 minutes (Fig. 4A, lanes 4–7).
Lysophosphatidic acid, a known mitogenic activator, induced FAK
phosphorylation at -Tyr397 in HaCaTs after 10 minutes (Fig. 4A, lane
8). Using an MOI of 0.15, we addressed the kinetics of FAK
phosphorylation during early infection (Figs. 4B and C). As before,
we observed an increase in pFAK-Tyr397 as early as 5 minutes and
determined that there was a biphasic increase in pFAK- Tyr397 with
peaks at 10 minutes and 30 minutes. These data showed that binding
of HPV16 PsV induced an increase in pFAK-Tyr397 in a time-dependent
manner. Signiﬁcance was assessed using a two-tail T-test at *pb0.05
(Fig. 4B, asterisk compared to no virus control lane 1). pFAK-Tyr397
fold induction varied somewhat from experiment to experiment but
were always statistically signiﬁcant and had similar biphasic kinetics
(n=5). All pFAK-Tyr397 values were normalized against total FAK and
actin.
To conﬁrm that the pFAK-Tyr397 induction observed were not due
to non-virion contaminants, i.e., a nonviral protein in our OptiPrep-
puriﬁed HPV16 (L1/L2/8fwb PsVs) preparation, we performed
identical experiments with a control “mock” virus production. The
cells for the mock virus production fractions were transfected with
only 8fwb, i.e., L1 and L2 proteins were not expressed, and thus, no
PsVs were produced. PsVs and mock preparation were analyzed in a
Coomassie blue-stained SDS–polyacrylamide gel and negative stain
electron microscopy (EM) (Fig. S2). As is evident, there are nonviral
proteins visualized in both PsV and mock PsV preparation by
Coomassie staining, but there are no viral particles observed in the
mock preparation by EM. We used these fractions to determine if FAK
phosphorylation was speciﬁc to PsV containing fractions, and indeed
FAK phosphorylation only occurred in PsV containing fractions
(Fig. 4D, lane 3 as compared to lane 2). All batches of viral
preparations used in pFAK-Tyr397 induction were similarly evaluated
for nonspeciﬁcity and purity of viral preparation (n=5).FAK inhibitor TAE226 prevents HPV16 pseudovirion induced FAK-Tyr397
phosphorylation
Interaction of cell surface integrins with the ECM induces recruit-
ment of FAK from the cytoplasm leading to the autophosphorylation
Fig. 4. HPV16 induces FAK-Tyr397 phosphorylation in HaCaT cells. (A) Cells were incubated with MOI 0.0015 HPV16 PsV for 5, 10, 15, and 30 minutes (lanes 4–7, respectively) and
MOI 0.15 HPV16 PsV for 10 and 30 minutes (lanes 2 and 3, respectively); uninfected cells are shown in lane 1. Control LPA (20 ng)-induced FAK-Tyr397 is shown in lane 8. Equal
amounts of NP-40 lysates resolved by 8% SDS–PAGE were blotted for phosphorylated FAK-Tyr397 (pFAK blot), total FAK (tFAK blot), and actin. (B) Graphical representation of
temporal pFAK-Tyr397 induction evaluated by Odyssey densitometry of Western blot shown in C. Uninfected cells assigned a value of 1 for comparison lane 1. (C) HaCaT cells were
infected with HPV16 (MOI 0.15) at the indicated times after infection. Cell lysates were resolved on an SDS–PAGE and incubated with pFAK-Tyr397, total FAK (tFAK), and actin
antibodies. Protein levels were measured using the Odyssey densitometer. (D) Lysates from uninfected HaCaT cells (lane 1), mock-infected HaCaTs with 8fwb mock viral fraction
(lane 2), or HPV16 PsVs (lane 3) were resolved on an SDS–PAGE and incubated with phosphorylated FAK-Tyr397 (pFAK), total FAK (tFAK), and actin. Uninfected cells are assigned a
value of 1 for comparison with values of pFAK fold increase. Protein levels were measured using the Odyssey densitometer. Signiﬁcance level was set at *pb0.05.
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been shown to inhibit extracellular matrix-induced autophosphoryla-
tion of FAK-Tyr397 (Liu et al., 2007). To conﬁrm thatHPV16 infectionwas
indeed inducing an increase in pFAK-Tyr397, we analyzed pFAK-Tyr397
levels and cellular pFAK-Tyr397 expression in the presence of TAE226
(courtesy of Novartis). We ﬁrst analyzed the cytotoxicity levels of
TAE226 on HaCaT cells (Fig. 5A) and determined that a loss of cell
viability was observed at greater than 5.0 μM of TAE226 (*pb0.05). Our
experiments on HaCaT cells were thus performed with the nontoxic
doses of 0.1, 1.0, and 2.0 μM of TAE226. The induction of pFAK-Tyr397
(Fig. 5B, lanes 2–5) was not observed in the presence of the three
TAE226 concentrations (Fig. 5B, lanes 6, 7, and 8). Induction of pFAK-
Tyr397 at 30 minutes was conﬁrmed using 20% FBS as previously
described (Fig. 5B, lane 9) (Krishnan et al., 2006).
FAK has been shown to selectively localize at focal adhesion sites
on the plasma membrane and upon ligand binding to an integrin
receptor, FAK is phosphorylated and thus activated at Tyr397
(Hildebrand et al., 1993). We employed immunoﬂuorescence assays
to observe pFAK-Tyr397 upon virus binding and infection. In this assay,
HaCaT cells were infected with HPV16 PsVs for 10 minutes, 30 min-
utes, 60 minutes, or 4 hours at 37 °C or virus was added to cells on ice
to allow virus to bind for 2 hours (0 minutes). We showed that in
uninfected cells, there was minimal to no detected pFAK-Tyr397 in
HaCaT cells in the presence or absence of TAE226 (Figs. 5C and D).
Binding of HPV16 PsVs did not induce a signiﬁcant change in the levels
of pFAK-Tyr397 in the presence or absence of TAE226 (Figs. 5E and F).
The levels of pFAK-Tyr397 detected in infected cells in the absence of
TAE226 increasedwith time and peaked at 30 minutes (Figs. 5G, I, andK) and decreased to what appears to be basal levels after 4 hours
(Fig. 5M). In contrast, we did not observe an increase in pFAK-Tyr397
in cells infected in the presence of TAE226 (Figs. 5H, J, L, and N). These
immunoﬂuorescence experiments showed that indeed TAE226 was
able to interfere with FAK phosphorylation, a ﬁnding that parallels our
levels of FAK phosphorylation in the protein Western blot analysis of
HPV16-infected cells pretreated with TAE226.
Inhibition of FAK activation but not Src family kinase inhibition
interferes with viral infection
One of the most well-studied signal transduction events after FAK
activation involves recruitment and activation of Src family kinase
members (SFK), primarily pp60c-src kinase (pSrc) (Parsons, 2003;
Schaller et al., 1994). To determine if Src was induced by HPV16 PsV
binding, we assessed the level of phosphorylated Src (pSrc-Tyr418)
upon virus binding. Our data showed that at PsVMOI of 0.15, there is an
increase in Src-Tyr418 phosphorylation upon virus binding that can be
prevented in thepresence of SFK inhibitor PP2 (data not shown).Having
determined that HPV16 PsV induced FAK-Tyr397 and Src-Tyr418
phosphorylation, we wanted to determine the biological signiﬁcance
of FAK and Src phosphorylation. FAK or SFK inhibitor (TAE226 or PP2,
respectively) pretreated HaCaT cells were infected with HPV16 PsV
containing the green ﬂuorescent protein (GFP) reporter plasmid and
harvested after 48 hours. As shown in Fig. 6A, there was a dose-
dependent decrease in infection in the presence of TAE226 with a
signiﬁcant 25% decrease in infection at 0.1 μM compared to untreated
cells at 0 μM(*pb0.02). IncreasingTAE226 concentrations to 0.5 μMand
6 C.Y. Abban, P.I. Meneses / Virology 403 (2010) 1–161.0 μM showed no signiﬁcant increase in percent inhibition (p=0.28
and 0.4, respectively) when compared to cells treated with 0.1 μM of
TAE226. However, at 2.0 μM, we saw a 53% inhibition of infectioncompared to untreated cells (*pb0.003) and a signiﬁcant increase in
percent inhibition compared to cells treated at 0.1 μM (**pb0.015).
Although increasing doses of TAE226, 4 μM and 6 μM, gave a continued
7C.Y. Abban, P.I. Meneses / Virology 403 (2010) 1–16decrease in infection, these higher inhibitor concentration levels were
10% and 23% more cytotoxic to the cells compared to 2 μM TAE226
treated cells (data not shown).
Similar infection experiments in the presence of 10 μM of the SFK
inhibitor PP2 had no effect on the percent infection with PP2 (Fig. 6B,
bar 4) as compared to untreated cells (Fig. 6B, bar 2). Although we
observed a decrease in infection with 20 μM of PP2 (Fig. 6B, bar 5), it
was not statistically signiﬁcant and 20 μMPP2was cytotoxic to cells in
a cell viability assay (data not shown). An inactive PP2 analog, PP3,
had no effect in infection at 10 μM (Fig. 6B, bar 6). In these
experiments, HaCaT cells treated with 2 μM of TAE226 again showed
a signiﬁcant 57% decrease in infection (Fig. 6B, bar 3, *pb0.05)
compared to untreated cells (Fig. 6B, bar 2). These data demonstrated
that TAE226 reduced the level of infection and that PP2 did not,
suggesting that FAK and not SFK members were important for HPV16
PsV infection.
Infection in FAK knockout cells is decreased
To further address the role of FAK in HPV16 infection and for a
better understanding of a FAK mediated infection, we addressed the
efﬁciency of infection in FAK null cells. Because human FAK negative
cells are currently not available, we employed the use of FAK−/−
DU3 MEFs and matched control FAK+/+ DU17 MEFs. We have
previously shown that infection of MEFs is efﬁcient using HPV16 PsVs
(Dabydeen and Meneses, 2009). HPV16 infection in DU3 cells was
signiﬁcantly less compared to infection of DU17 cells (Fig. 6C, ﬁrst and
second bars, *pb0.05), but the lower level of infection in DU3 cells
suggests that there may be a FAK-related molecule that may partially
compensate for the role of FAK. Infection of DU3 MEFs treated with
TAE226 resulted in a signiﬁcant decrease in infection (Fig. 6C, last bar,
*pb0.05), as compared to TAE226-treated DU17 or untreated DU3
cells. Because PyK2, a non-receptor tyrosine kinase, has been shown
to be expressed and phosphorylated in DU3 cells, and a second target
of TAE226 (Cheshenko et al., 2005; Krishnan et al., 2006; Sieg et al.,
1998), we are currently investigating if PyK2 can compensate for the
role of FAK during PsV infection.
Blocking α6 integrin function prevents FAK-Tyr397 phosphorylation
Our data suggested that α6 integrin was important for infection
and that FAK phosphorylation (and thus activation) upon PsV binding
was induced and necessary for infection. To determine if there was a
link betweenα6 integrin function, PsV binding and FAK activation, we
performed an experiment in the presence of an α6 integrin functional
blocking antibody in MEFs. FAK phosphorylation was observed at
10 minutes after infection (Fig. 6D, lane 2) and with the positive
control 20% FBS (Fig. 6D, lane 3 as compared to uninfected cells in lane
1). Addition of an α6 integrin functional blocking antibody prevented
the FAK phosphorylation in the presence of PsV (Fig. 6D, lane 4). This
demonstrates that the α6 integrin plays a role in mediating FAK
phosphorylation and that blocking α6 function in the presence of PsV
blocks FAK phosphorylation. FAK knockoutMEFs are shown as control
for FAK staining (Fig. 6D, lanes 5–8). We have also tested the ability of
blocking FAK phosphorylation with functional antibodies againstFig. 5. Phosphorylation of FAK is blocked in HaCaT using TAE226. (A) Cytotoxicity of TAE22
0 μM, 0.1 μM, 1.0 μM, 2.0 μM, 5.0 μM, and 10 μMwere tested. Cell viability was assessed after
the cells (signiﬁcance level was set at *pb0.05). (B) HaCaT cells were infected with HPV16 vi
presence of TAE226 at 0.1, 1.0, and 2.0 μM (lanes 6–8); or incubated with 20% FBS for 30 m
phosphorylation (pFAK-Tyr397), total FAK (tFAK), and actin blots (actin) were determined us
normalized to actin control. Uninfected cells are assigned a value of 1 for comparison with v
lanes 6–8) was determined by dividing the decrease in FAK phosphorylation in inhibitor-tre
the absence of inhibition. (C–N) Visualization of FAK phosphorylation by immunoﬂuorescen
0.15 for 0, 10, 30, and 60 minutes and 4 hours, respectively. In panels F, H, J, L, and N, cells
4 hours, respectively. Immunoﬂuorescence was performed with anti-pFAK-Tyr397; nuclei
objective. Control uninfected cells stained for pFAK and nuclei are shown (C, D).integrin receptors α3 and α2; we did not see a decrease in FAK
phosphorylation (data not shown).
TAE226 prevents closure of gap in a wound healing model
Infection of HPV has been suggested to be supported by awounded
epithelium (Roberts et al., 2007). The process of wound healing
requires cell migration (Mattila and Lappalainen, 2008), and FAK
kinase activity has been demonstrated by Sieg et al. (1999) to play an
important role in cell migration. Thus, we wanted to determine if
inhibiting FAK phosphorylation (i.e., activation) will inhibit migration
of HaCaT cells and if this migration loss was responsible for our
observed loss of infection. In the next set of experiments, we assessed
the process of migration in an in vitro “wound healing” model in the
presence and absence of the FAK inhibitor TAE226. In this wounding
assay, HaCaT cells plated to conﬂuence were wounded (scraped) in
the form of a plus sign with a 10-μl pipette tip, as has been previously
described (Slack-Davis et al., 2007). Inhibitors were added to the cells,
and the percentage of wound closure was monitored at 24 and
36 hours. The closure of the gap in control DMSO-treated cells was
compared to TAE226 treated cells (Fig. 7). Wound (scrape) area in
control (DMSO-treated cells) cells was 75% closed after 24 hours and
more than 90% after 36 hours (Figs. 7A–C, and J cells alone bars).
Addition of TAE226 at a nontoxic dose of 2 μM was able to block
wound healing by greater than 95% for up to 36 hours (Figs. 7D–F and
J-TAE226 bars).
Because HPV31 was shown to induce the formation of ﬁlopodia
upon binding to target cells and ﬁlopodia are necessary to aid in
closing the wound via formation of adherens junctions between
epithelial cells (Mattila and Lappalainen, 2008; Smith et al., 2008), we
tested if the addition of HPV16 PsV to TAE226 pretreated cells would
induce cell migration that would counteract the loss of migration
observed in the presence of TAE226. Our data showed that in this
model of wound healing, TAE226 prevented migration that would
lead to gap closure and addition of HPV16 PsV did not induce gap
closure in the presence of TAE226. Addition of HPV16 PsV had no
effect on the size of the gap in the presence of TAE226 (Figs. 7G–I, and
J-TAE226 with virus bar) or in the absence of TAE226 (data not
shown).
HPV16 PsV induce ﬁlopodia formation
Because wound healing requires ﬁlopodia formation and HPV16
PsV did not affect wound closure, we wanted to assess if HPV16
indeed induced ﬁlopodia formation as HPV31. As compared to cells
alone or to cells in the presence of TAE226 (Figs. 8A and B,
respectively), the induction of ﬁlopodia is highly increased with the
addition of HPV16 PsV at 10 minutes (Fig. 8C, white arrow). There is a
subsequent decrease in the induction of ﬁlopodia in the presence of
virus at 30 minutes (Fig. 8E, white arrow). Althoughwe observed PsVs
at the plasmamembrane in the presence of TAE226, we did not detect
any ﬁlopodia formation in the presence of TAE226 (Figs. 8D and F,
yellow arrow shows virus and actin overlap). These data demonstrate
that inhibiting FAK phosphorylation can prevent HPV16 PsV-induced
ﬁlopodia formation. We noticed that, in the absence of ﬁlopodia6 was not observed on HaCaTs up to 2 μM concentration. Increasing concentrations of
48 hours as a function of the level of ATP. Doses of 5.0 μM and 10.0 μMwere cytotoxic to
rus (MOI 0.15) for 5, 10, 15, and 30 minutes in the absence of TAE226 (lanes 2–5), in the
inutes (lane 9). Equal amounts cell lysates were run on an 8% SDS–PAGE. Levels of FAK
ing corresponding antibodies. Values were normalized based on tFAK values which were
alues of pFAK fold increase. The percent inhibition of FAK phosphorylation (bottom of
ated cells after 30 minutes of infection to FAK induction after 30 minutes of infection in
ce confocal microscopy. In panels E, G, I, K, and M, cells were infected with HPV16 MOI
preincubated with 2.0 μM of TAE226 were infected for 0, 10, 30, and 60 minutes and
are visualized with TOPRO-3 (blue). Confocal images were obtained using a 60× oil
8 C.Y. Abban, P.I. Meneses / Virology 403 (2010) 1–16formation (i.e., in TAE226-treated cells), PsV colocalized with actin
was observed at the plasmamembrane (compare Figs. 8C to D and E to
F, yellow arrow shows overlap of actin and PsV). These results(Figs. 8D and F) provide evidence that TAE226 does not interfere with
virus binding to the plasma membrane, suggesting that endocytosis
may be inhibited.
Fig. 7. TAE226 inhibits gap closure in HaCaT wound closure model. (A–I) HaCaTmonolayers grown to near conﬂuence were incubated in the presence or absence of 2.0 μMTAE226±
HPV16 PsV at the time of wounding. DMSO was used as a vehicle control. Images were obtained by light microscopy with a 4× objective lens. (J) Percentage gap closure represented
as a bar graph (black bars represent gap closure at 24 hours, grey bars represent gap closure at 36 hours). Error bars represent the standard deviations of the percent gap closure
measured within a marked area of at least 4 data points. Gap closure was calculated by the percentage change in area at greater than four data points and calculated by the formula:
(area of scratch wound at time 0)− (area of scratch wound after 24 or 36 hours) / 100. Signiﬁcance was determined by Student's t test and p value set at pb0.05: *signiﬁcance at
24 hours, **signiﬁcance at 36 hours.
9C.Y. Abban, P.I. Meneses / Virology 403 (2010) 1–16TAE226 prevents HPV16 endocytosis into early endosomes
Because our data showed that TAE226was not interferingwith PsV
binding to HaCaT cells, they suggested that TAE226 was interfering
with endocytosis, and thus infection. We analyzed endocytosis of PsV
in conﬂuent and subconﬂuent monolayers (Figs. 9 and S3). Following
HPV16 PsVs attachment to target cells, PsVs have been shown to be
endocytosed into early endosomes. TAE226 did not prevent the
binding of viral particles to HaCaTs (Figs. 8D and F, red arrow) but did
prevent the overlap of PsVs with the early endosome marker EEA1
(green arrow) in both subconﬂuent and conﬂuent HaCaT monolayers
(Figs. 9 and S3, respectively). HPV16 PsV staining overlaps with EEA1
at 10 and 30 minutes and is observed for the ﬁrst 4 hours (Figs. 9E, G, I,Fig. 6. FAK phosphorylation inﬂuences HPV16 infection. (A) TAE226 inhibits HPV16 PsV infec
GFP cDNA in the presence of 0 μM, 0.1 μM, 0.5 μM, 1.0 μM, and 2.0 μM TAE226. Infection w
deviations of the mean from three separate experiment, *pb0.02, **pb0.015 (Student's t tes
kinase inhibitor PP2. The inactive PP2 analog PP3 was used as a control. Cells were infected
Error bar represents the standard deviations of the mean from three separate experiments
*pb0.05. (C) FAK expressing (DU17) and FAK knockout DU3 MEFs cells infected in the pre
HPV16 GFP reporter PsVs, and percent infection was measured by ﬂow cytometry. Error ba
triplicate). Signiﬁcance was determined by Student's t test and p value was set at *pb0.05. (D
PsV (lane 2), incubated with 20% FBS (lane 3), or infected with HPV16 in the presence of an an
FAK knockout cells (lanes 5–8). Lanes 1–8, NP-40 lysates were run on an 8% SDS–PAGE and le
(lower band). Loading values were normalized based on total FAK expression, whichwas nor
of 1 (lane 1) for comparison.and K and Fig. S3). In contrast, we did not observe any overlap of
HPV16 PsV staining with EEA1 in TAE226-treated cultures (Figs. 9F, H,
J, and L and Fig. S3). These data strongly support the hypothesis that in
addition to preventing ﬁlopodia formation, TAE226 is blocking the
initial step of HPV16 PsV endocytosis into the early endosomes.
α6 Integrin surface expression is necessary for HPV16 infection of KH-SV
cells
Having shown that an α6 integrin functional blocking antibody
prevented FAK phosphorylation and that blocking FAK phosphoryla-
tion interfered with HPV16 infection, we addressed infection in the
presence of α6 integrin targeted siRNA. In our control cells (Fig. 10C),tion in a dose-dependent matter. HaCaT cells were infected with HPV16 PsV carrying the
as measured by FACS analysis for GFP positive cells. Error bar represents the standard
t). (B) HPV16 PsV infection level was decreased with TAE226 but not by the Src Family
with HPV16 GFP reporter PsVs, and percent infection was analyzed by ﬂow cytometry.
(in triplicate). Signiﬁcance was determined by Student's t test and p value was set at
sence or absence of the FAK kinase inhibitor TAE226 (2 μM). Cells were infected with
r represents the standard deviations of the mean from three separate experiments (in
) FAK expressing MEFs (DU17) (uninfected control in lane 1) were infected with HPV16
ti-α6 functional blocking integrin antibody (lane 4). No FAK expression was detected in
vels of phosphorylated FAK-Tyr397 (top bands), total FAK (middle band), and actin blots
malized to actin values. Uninfected cells FAK phosphorylation levels are assigned a value
Fig. 8. TAE226 inhibits ﬁlopodia formation but not virus binding. (A and B) Mock-infected HaCaT cells in the absence and presence of 2.0 μM TAE226, respectively. (C and E) HaCaT
cells infected with virus for 10 and 30 minutes in the absence of inhibitor, respectively. (D and F) HaCaT cells preincubated with 2.0 μM TAE226 infected for 10 and 30 minutes,
respectively. Actin is viewed using phalloidin-488 (green); HPV PsVs are stained with anti-HPV16.V5 antibody; actin overlapping with HPV PsVs is observed (yellow). Filopodia
extensions (white arrows) and virus colocalizing with the phalloidin-stained actin (yellow arrows) are shown. Nuclei are visualized with TOPRO-3 (blue).
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FACS) was 22,469, whereas the mean ﬂuorescence intensity for
surface expressed α6 integrin was decreased to 3537 in α6 integrin
siRNA-transfected cells (Fig. 10E). Infection of α6 siRNA-transfected
cells (Fig. 10F) was reduced by over 90% as compared to infection of
control cells (Fig. 10D). Control IgG and uninfected cells are shown for
comparison (Figs. 10A and B, respectively). Next, infection was
measured by real-time RNA RT–PCR using GFP mRNA as target.
Graphical representation of infection analysis is shown with the
addition of siRNA-only cells to ensure no background signal due to
siRNA transfection. These data clearly show that a drop in α6 integrin
surface expression results in a signiﬁcant loss of infection.
Discussion
The ﬁndings described in this article provide evidence that HPV16
initially attaches to HaCaT cells via a heparan sulfate proteoglycan
(HSPG) and subsequently mediates a signal transduction event
through the α6 integrin and FAK.
Our data have shown that HPV16 reporter virions binding to an
immortalized keratinocyte cell line can be blocked by soluble
heparin and decreased by heparinase I treatment of cells, thus
supporting the need for HSPGs for viral attachment. For instance,
Girouglou et al., in looking at the infectious entry pathway of HPV33
pseudovirions and HPV16 binding have shown that initial virion
binding to COS-7 cells involves the HSPG receptor (Girouglou et al.,
2001; Selinka et al., 2002) and Joyce et al. (1999) have shown that
the L1 conserved major capsid protein of HPV11 binds to HSPGs. In
our experiments, soluble heparan blocked binding by over 90% andremoval of heparan sulfate by heparinase I decreased binding by 75–
80%. This decrease in binding corresponded to a 75–80% drop in
infection. Possible reasons why we cannot attain a 100% infection
block includes the possible inefﬁciency of heparinase I, the inability
of soluble heparin to mask all binding sites on every infectious
particle, and the possibility that there is a low level of heparan
sulfate-independent infection in our culture system. Our data
support the animal studies using a cervicovaginal challenge mouse
in vivo model that demonstrated that heparinase III blocked HPV16
infection and binding (Johnson et al., 2009).
It has been well documented that neutralization of HPV infection
can be achieved after viruses bind to the cell surface (Day et al., 2007).
This suggests that a secondary event is needed for internalization. In
this article, our data showed that this possible secondary event is the
binding of the viral particle to an integrin, and in HaCaTs, α6 may be
the most critical. Using siRNA targeting α6 mRNA, we were able to
decrease surface expression of α6 integrin receptor, including
complete loss of detection in about 30% of integrin-positive KH-SV
cells. This decreasewas able to reduce infection bymore than 90%. The
remaining infection can be attributed to the inability of 100% removal
of surface expressed α6 integrin receptor or to a non-α6-dependent
infection event.
The role of the α6 integrin receptor in HPV16 infection led us to
demonstrate for the ﬁrst time that the FAK molecule is phosphorylated
upon HPV16 binding to a keratinocyte cell line. The data demonstrated
FAK phosphorylation as early as 5 minutes, suggesting that phosphor-
ylation of FAK may be one of the initial signaling molecules activated
upon ligand binding to HaCaT cells. The FAK phosphorylation was
detected at Tyr-397, a site of autophosphorylation. We did observe an
Fig. 9. TAE226 prevents HPV16 trafﬁcking to the early endosome. Control uninfected HaCaT cells without (A) or with TAE226 (B). HPV16 binding to HaCaT cells (C) is not affected by
TAE226 (D). PsVs internalization in the absence (E, G, I, K) or presence (F, H, J, L) of TAE226 at the corresponding time. Cells were ﬁxed, permeabilized, and stained for the early
endosome marker EEA1 (green), and HPV16 PsV with anti-HPV16.V5 antibody. Nuclei are visualized with TOPRO-3 (blue). HPV16 PsVs (red arrows) did not colocalize with EEA1
(green arrows) at 10, 30, and 60 minutes or 4 hours in TAE226-treated cells. Confocal images were obtained using a 60× oil objective.
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often observed after FAK activation. Although FAK and Src were both
phosphorylated and thus activated, only FAK was demonstrated to be
biologically important. HPV16 infection was signiﬁcantly decreased in
the presence of TAE226-treated cells, whereas infection levels did not
decrease with the addition of a Src family kinase (SFK) inhibitor, PP2.
Wealso showed that in thegenetically alteredMEFs,HPV16 inductionof
FAK was blocked in the presence of an α6 integrin functional antibody,
suggesting that indeed FAK activation by HPV16 was dependent on α6
integrin.Although our data suggested that TAE226 prevented wound
closure and ﬁlopodia formation to the same extent as PP2, we saw
that inhibiting cell migration and ﬁlopodia formation is not enough to
prevent infection because PP2 did not reduce infection. This suggested
that TAE226 was interfering with endocytosis, and our viral entry
immunoﬂuorescence studies conﬁrmed that entry to the early
endosomes was inhibited by TAE226.
Our data are consistent with studies on the infectious pathway of
HPV infection on other cell lines that had identiﬁed the HSPGs and
α6β4 as attachment factors and putative receptors, respectively
12 C.Y. Abban, P.I. Meneses / Virology 403 (2010) 1–16(Giroglou et al., 2001; Joyce et al., 1999; McMillan et al., 1999;
Rommel et al., 2005; Shafti-Keramat and Handisurya, 2003). The
internalization of viruses that utilize HSPG and integrin receptorbinding suggested a role for FAK and Src signaling in entry
(Cheshenko et al., 2005; Krishnan et al., 2006). The role of FAK has
been implicated in herpes simplex virus (HSV) entry (Cheshenko
13C.Y. Abban, P.I. Meneses / Virology 403 (2010) 1–16et al., 2005) and human herpesvirus 8 (HHV8) both enveloped DNA
viruses, and although FAK phosphorylation has been observed in the
adenovirus (a nonenveloped virus) infection of human corneal
ﬁbroblasts, its role has yet to be deﬁned (Natarajan et al., 2002).
Our data suggest that α6 integrin is mediating a signaling event that
involves FAK phosphorylation and that interfering with FAK function
or α6 expression can reduce or prevent infection.
Based on the ﬁndings presented in this article, we hypothesize that
after HSPG binding, HPV viral particles interact with α6 integrin
leading to FAK phosphorylation. FAK phosphorylation is then
responsible for activating downstream molecules necessary for
endocytosis and intracellular trafﬁcking. We are exploring the
possibility that PyK2 may in part contribute to HPV16 infection.
There exists the possibility that HPV16 entry may be partly through
nonclathrin/caveolae mechanisms, e.g., tetraspanins (Spoden et al.,
2008). Although the tetraspanin link has been shown in nonkerati-
nocyte cell line thus far, the role of integrins would still be applicable
because tetraspanins form complexes with integrin receptors
(Berditchevski and Odintsova, 1999). We are addressing if there is a
link between tetraspanins, integrins, and FAK phosphorylation during
HPV16 PsV infection.
Materials and methods
Cells
HaCaT cells originally derived from the lab of Dr Fusenig (The
German Cancer Research Center, Heidelberg, Germany) were given as
a gift from Dr Ozbun (The University of New Mexico School of
Medicine, Albuquerque, NM)(Boukamp et al., 1988). The primary
mouse embryonic ﬁbroblasts FAK −/− DU3 and their matched
control FAK+/+DU17 cells described by Ilic et al. (1995) (University
of California at San Francisco) were a generous gift from the Chandran
Laboratory (Rosalind Franklin University of Medicine and Science
(RFUMS) North Chicago, IL). Cells were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% fetal
bovine serum (FBS, DMEM-10), 100 IU/ml penicillin, and 100 µg/ml
streptomycin. KH-SV keratinocytes from a healthy donor and BOUA-
SV α6 integrin negative keratinocyte cells from a patient with pyloric
atresia–junctional epidermolysis bullosa (PA-JEB) were immortalized
using simian virus 40 (laboratory of Guerrino Meneguzzi), and shared
with us by Dr. Christensen (Penn State University, Hershey, PA)
(Gache et al., 1998). Cells were maintained in KGM medium (Lonza)
containing KGM SingleQuots, bovine pituitary extract, human
epidermal growth factor, insulin, hydrocortisone, and gentamicin/
amphotericin B selection (KH-SV) or G418 (400 µg/ml) selection
(BOUA-SV α6 integrin negative).
Determination of the number of viral particles
The signaling events induced at the plasma membrane are a result
of the number of viral particles binding to the cells surface receptors.
In our experiments, infection is detected by the expression of GFP at a
multiplicity of infection (MOI) of 0.15, i.e., 0.15 infectious units/cell.
Using real-time PCR, we determined the number of genomes in our
preparation to be 8×107 viral particles or 12 DNA containing viral
particles per cell when using an MOI of 0.15. To measure all the viral
particles used, we measured the amount of L1 protein in our viral
preparation by comparing L1 levels to a control amount of BSA in aFig. 10. siRNA knockdown of α6 integrin expression decrease HPV16 infection in KH-SV cells
of control uninfected KH-SV cells. (C–F) KH-SV cells were double transfected with α6 siRN
infection wasmeasured by ﬂow cytometry. Panels: (C)α6 integrin expression level in contro
siRNA-expressing cells, (F) level of HPV16 infection in α6 siRNA-expressing cells, (G) real-tim
plasmid). Graph shows real-time GFP RT–PCR of infected and uninfected cells after 48 hours
signal was detected in α6 siRNA-transfected cells in the absence of HPV16 PsV infection (laCoomassie stained gel. We measured 8×109 viral capsids in 0.15 MOI
or 1200 viral particles per cell/experiment.
HPV16 pseudovirion (PsV) production and puriﬁcation
HPV16 PsVs were made in 293TT as described by Buck et al.
(2004). 293TT cells, bicistronic HPV16 L1 and L2 plasmid pShell, and
the GFP cDNA plasmid 8fwb were a generous gift from Drs. Day and
Schiller (NCI/NIH Bethesda, MD). In brief, pShell and 8fwb were
transfected into 293TT cells and harvested, and after high-salt
extraction, PsV were puriﬁed on the OptiPrep gradient (27–39%).
The viral fractions used were analyzed under negative staining
electron microscopy and by Coomassie staining on a sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE). Viral titer
(MOI) was determined by measuring the percentage of GFP positive
cells, i.e., infected HaCaT cells after 48 hours, by FACS analysis. The
number of genome containing viral particles used in experiments was
quantiﬁed by real-time PCR. The total number of viral particles
(empty particles and genome containing particles) was measured by
determining the L1 protein levels on a Coomassie-stained SDS–PAGE.
3[H] Thymidine-labeled PsV was generated by the addition of 3[H]
thymidine to the cultures during viral production.
Antibodies and reagents
Phospho-FAK (pY397), FAK, phospho-Src (pY418), and Src anti-
bodies were purchased from Upstate Biotechnology (Lake Placid, NY),
and anti-mouse integrin α6 (CD49f) functional blocking monoclonal
antibody was purchased from Chemicon International. F58-10E4 anti
heparan sulfate monoclonal antibody was purchased from a Seikagaku
Corporation subsidiary, Associates of Cape Cod, MA. Lysophosphatidic
acid was purchased from Sigma (St. Louis, MO) and PP2 Src family
kinase (SFK) inhibitors were purchased from Calbiochem. Puriﬁed
TAE226 was generously supplied by Novartis Pharma, AG, Switzerland.
TAE226 was dissolved in DMSO (Sigma Aldrich) to a concentration of
10 mmol/L, stored at −20 °C. Working dilutions of TAE226 at varying
concentrations of 0.1, 0.5, 1.0, 2.0, 2.5, 3.0, 4.0, 5.0, and 6.0 μM were
made by resuspending stock solution in DMEM-10 before use. In
experiments, control cells were incubated with an equal amount of
DMSO diluted in DMEM-10.
Inhibitor studies
HaCaT cells were preincubated at 37 °C with indicated doses of
PP2, PP3, or TAE226 for 1 hour before the addition of virus. The
inhibitors weremaintained on cells throughout the experiment unless
indicated.
Cell viability assay
The cell toxicity of inhibitors used in experiments was determined
using the Cell Titer-Glo luminescent cell viability assay (Promega,
Madison, WI). HaCaT cells in a 12-well tissue culture dish at 100,000
cells per well were incubated with increasing concentrations of
inhibitor at 37 °C for 48 hours. At 48 hours after incubation, super-
natants were collected and cells were harvested with trypsin and
added to their corresponding supernatants. Cell viability was assessed
in accordance with the manufacturer's recommendations of the
luminescent cell viability assay kit by Promega, Madison, WI.. (A) IgG isotype staining of control uninfected KH-SV cells. (B) Flow cytometry analysis
A or control siRNA; after 72 hours, cells were infected with HPV16 PsVs and level of
l cells, (D) level of HPV16 infection in control cells, (E)α6 integrin expression level inα6
e RT–PCR analysis for the expression of GFP mRNA (HPV16 PsV encapsidate GFP cDNA
. HPV16 GFP expression in the absence of siRNA treatment was considered as 100%. No
st bar). Each condition was performed in triplicates.
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Cytotoxicity of the inhibitor wasmeasured by a statistically signiﬁcant
drop in ATP levels relative to that of untreated cells. Each
concentration was tested three times, and the error bars represent
standard deviations. Cell viability was also conﬁrmed using a trypan
blue exclusion assay.
Detection of FAK and Src phosphorylation
A total of 500,000 HaCaT cells plated on a 10-cm2 dish at 37 °C in
DMEM-10were serum-starved in DMEM for 48 hours. Cells were then
infected with HPV16 PsV typically at MOI of 0.15 to achieve infection
of approximately 15% cells, unless indicated. At different time points,
HPV16-infected cells were harvested. Cells were lysed in cold 0.5%
Nonidet P-40 (NP-40) buffer (0.5% NP-40, 150 mM NaCl, 10 mM Tris
pH 7.5, 5 mM EDTA, and 1× protease inhibitor cocktail (PIC, GE
Healthcare)). Lysates were clariﬁed at 13,200×g at 4 °C for 10 min-
utes, and protein concentration was determined using a bicinchoninic
acid (BCA) protein kit (Pierce, Rockford, IL). Equal amounts of protein
lysates were denatured at 95 °C for 5 minutes, resolved on an 8% SDS–
PAGE, and transferred to nitrocellulose membrane. Membranes were
immunoblotted with primary antibodies pY397-FAK, pY418-Src, and
anti-actin at 1:1000 overnight at 4 °C. Anti-mouse and anti-rabbit
Alexa Fluor 680 nm and 800 nm secondary antibodies were used at
1:20,000 for 30 minutes at room temperature. Equal protein loading
was also conﬁrmed using anti-FAK and anti-Src (total FAK or Src)
antibodies at 4 °C overnight. Odyssey Imaging System and software
(Li-Cor, Lincoln, NE) were used to scan and analyze band intensity.
Confocal microscopy colocalization studies
HaCaT cells at 100,000 cells per well were plated on a 6-well plate
containing glass coverslips and incubated overnight in DMEM-10 at
37 °C (Fisher Scientiﬁc, Piscataway, NJ. catalog no. 12-545-80). After
24 hours, cells were serum-starved in DMEM for 48 hours at 37 °C.
After 48 hours, HPV16 PsV at an MOI of 0.15 was added to cells and
incubated for the described length of time at 37 °C. Cells were ﬁxed for
10 minutes in 4% paraformaldehyde in PBS at 4 °C and washed 3× in
1× PBS. Cells on coverslips were permeabilized with blocking buffer
(0.2% ﬁsh skin gelatin (Sigma), 0.2% Triton X-100 in PBS) for
5 minutes. Coverslips were washed 3× in 1× PBS and incubated
with mouse anti-HPV16.V5 antibody (provided by Dr. Christensen),
the early endosome marker goat anti-EEA1 (Santa Cruz, California),
Alexa Fluor 488 phalloidin (Molecular Probes (Invitrogen), Carlsbad,
CA), and mouse anti-pFAK (Millipore, Upstate). Primary antibodies
were used at a dilution of 1:100 and incubated on cells for 1 hour. The
ﬂuorescence-labeled Alexa Fluor secondary chicken anti-goat 488 and
donkey anti-mouse 594 antibodies were used at a dilution of 1:2000.
All dilutions were made in blocking buffer. Nuclei were stained with
TOPRO-3 (1:1000 dilution in blocking buffer) (Invitrogen), and
coverslips were mounted using Prolong Gold Anti-Fade (Invitrogen).
Fluorescence confocal microscopy was performed on an Olympus
Fluoview 300 inverted confocal microscope and image analysis was
done using Fluoview software (Olympus, Melville, NY) at the
microscopy core of RFUMS. Z-stacked images were taken at 0.75-μm
sections of the cell in an x, y, and z plane (7 sections/z stack).
Wound healing model assay
HaCaT cells were plated in serum-free medium at 300,000 cells per
well. At 24 hours later cells were near conﬂuence, a plus sign was
manually scraped in the monolayer of cells using a sterile 10-μl
pipette tip. After scraping, cells were washed 3× with 1× PBS to
remove any ﬂoating cells. Inhibitors or control vehicle was added for
the described length of time, areas of gap weremarked at greater than
four matched pairs of gap, and then gap closure was measured usingthe ruler tool on the Nikon inverted microscope TE-2000S with a 4×
objective lens. Images were captured andmeasured usingMetamorph
imaging software. Area of gap closure was calculated by the
percentage change in area at greater than four data points and
calculated by the formula: (area of scratch wound at time 0− area of
scratch wound after 24 or 36 hours)/100.
Measuring HPV16 PsV binding
To measure virus binding, 3[H] thymidine-labeled virus was
incubated with a monolayer of cells on ice at 4 °C for 2 hours.
Unbound virions were washed off by washing 4× with 1× PBS. Cells
were harvested by scraping, centrifuged at 10,000×g for 10 minutes
and resuspended in 20 μl of 1× PBS. Cells were spotted ontoWhatman
paper, allowed to dry for 10 minutes. Radioactivity was precipitated
with 5% trichloroacetic acid (TCA) (Fisher Scientiﬁc) and counted in a
Beckman Coulter scintillation counter.
Removal of cell surface heparan sulfate using heparinase I
Heparinase I purchased from Sigma, St. Louis, MO, was recon-
stituted in digestion buffer (50 mM HEPES, 50 mM sodium acetate,
150 mM NaCl, 9 mM CaCl2, and 0.1% BSA (pH 7.0)). Cultures were
washed 1× with digestion buffer, treated with increasing units of
heparinase I for 1 hour at 37 °C, and then washed thoroughly with 1×
PBS.
Determining integrin proﬁle of cells
HaCaT cells, KH-SV, and BOUA-SV α6 integrin negative cells were
plated in 10-cm2 tissue culture plates at 2×106 cells per plate. After
48 hours at 80% conﬂuence, cells were detached with 5 mM EDTA at
pH 7.4 for 10 minutes at room temperature. Integrin expression levels
were analyzed using an integrin-mediated cell adhesion ﬂuorimetric
array (Chemicon International, catalog no. ECM 535). Integrin array
kit recognizes extracellular epitopes of human α and β integrins. In
this kit, the wells of a 96-well plate contain immobilized monoclonal
human integrin antibodies used to capture cells expressing integrins
on their surface. Unbound cells were washed off and adherent cells on
the plate were lysed, and integrins were detected using molecular
probes CyQuant GR dye. Absorbance was determined at 540–570 nm
on a microtiter plate reader.
HPV16 infection assay
HaCaTs, KH-SV, BOUA-SV, DU17, or DU3 cells were plated at
50,000 in a 24-well plate. After 24 hours, HPV16 PsVs were added to
cells and bound for 2 hours on ice. Unbound virions were removed by
washing 2 times (2×) with appropriate media. Cultures were then
incubated at 37 °C for 48 hours. Infection was measured as the
percentage of GFP-transduced cells because the PsV-encapsidated
plasmid 8fwb encodes the GFP cDNA. Infections were analyzed by
FACS at RFUMS ﬂow cytometry core. FACS analysis was done using the
CellQuest Pro software (BD Biosciences).
Flow cytometry analysis of infection
Cells infected with PsVs in the presence or absence of inhibitors
were harvested andwashed 3× in 1× PBS. Cells in PBS were processed
by ﬂow cytometry on a FACS-Calibur sorter (Becton-Dickinson, San
Jose, CA) to determine infection efﬁciency based on GFP ﬂuorescence.
siRNA knockdown of α6 integrin in KH-SV
KH-SV cells at 50% conﬂuence on a 6-well dish (approximately
400,000 cells) were transfected with 1 μM Accell siRNA in 750 μl of
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fected with 1 μM Accell siRNA in Accell delivery medium. Transfected
cells were incubated for 24 hours and infected with HPV16 PsVs.
HPV16 infection went for 48 hours. The level of α6 integrin
knockdown was determined via ﬂow cytometry analysis of cells
using the α6 integrin preconjugated PE–Cy5 rat anti-human antibody
CD49f (BD Biosciences). IgG2a PE-Cy5 Rat anti-human isotype
antibody was used to control for nonspeciﬁc ﬂuorescence. HPV16
infections on cells transfected with α6 siRNA or control siRNA were
monitored via ﬂow cytometry analysis.
Determining level of HPV16 infection by (GFP transgene) real-time
RT–PCR
Total RNA was isolated from infected or uninfected cells using Tri
Reagent Solution, Ambion. HPV16 8fwb GFP expression was detected
by real-time RT–PCR using GFP gene speciﬁc primers and Sybr Green
real-time PCR mix from Applied Biosystems. The samples were
normalized to 18s RNA gene expression.
Electron microscopy analysis of viral particles
A total of 5 μl of OptiPrep-puriﬁed HPV16 PsVs and the mock viral
preparation were added to formvar-carbon-coated 400 mesh copper
grids for 5 minutes. Grids were stained with 4% phosphotungstic acid
(PTA) for 1 minute and washed with distilled water for 30 seconds.
We allowed grids to dry, and negative stained micrographs were
digitally acquired using a JEOL JEM-1230 transmission electron
microscope at 80,000 magniﬁcation.
Statistical analysis
We performed all experiments at least three times with each
condition in triplicate. Error bars shown represent data means±SD.
Data were analyzed for signiﬁcance as needed using paired t-tests
seeking 95% conﬁdences.
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